CION Ameerpet
Childhood Cancer Types — Parent’s Guide
Other soft-tissue sarcomas in children — what parents need to know
Medically reviewed by Dr. Muralidhar Muddusetty, MCh (Surgical Oncology) · Last reviewed June 2026
If your child has been told they may have a soft-tissue sarcoma that is not rhabdomyosarcoma — or if you are trying to understand what a term like “synovial sarcoma” or “non-rhabdo sarcoma” means — this page is written for you. These cancers arise in the connecting tissues of the body and can appear at almost any site. Each type behaves differently, and each requires specialist assessment before a treatment plan is made. We walk through what these tumours are, how to recognise a lump worth evaluating, and how the diagnostic and treatment journey unfolds.
- Tumour board for every child — a full surgical, medical, and radiation oncology team reviews each case before any treatment begins
- 45-minute consultations — time to hear your full story and explain the reports in plain language, no rushed decisions
- Limb-sparing surgery expertise — experienced sarcoma surgeons aiming to preserve function wherever oncologically safe
- Free first consultation — paediatric sarcoma assessment at no charge for first-time patients; bring any existing scans or reports
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding the diagnosis
What is a soft-tissue sarcoma in a child?
The word “sarcoma” refers to a cancer that begins in connective tissue — the structural material that holds the body together and supports its organs. Soft connective tissues include muscle, fat, the walls of blood vessels and lymph vessels, nerves, tendons, and the fibrous tissue that lines joints. When cancer develops in any of these tissues, it is called a soft-tissue sarcoma. This is different from carcinomas (which begin in the cells lining organs such as the lung, bowel, or breast) and from bone sarcomas (which begin inside bone itself).
In children, the most common soft-tissue sarcoma is rhabdomyosarcoma, which arises specifically in skeletal muscle. All other soft-tissue sarcomas in children are grouped under the term non-rhabdomyosarcoma soft-tissue sarcomas (NRSTS). These include a range of distinct tumour types — synovial sarcoma, infantile fibrosarcoma, epithelioid sarcoma, clear cell sarcoma, and others — each of which has its own biology, its own typical pattern of spread, and its own response to treatment. Because the NRSTS group contains so many different tumour types, it is essential that the exact subtype be confirmed before any treatment is planned.
Soft-tissue sarcomas in children can appear at almost any site in the body. The most common locations are the limbs (arms and legs, particularly around the major joints), the trunk, and the head and neck. A soft-tissue sarcoma most often presents as a lump or mass. In many cases, the lump is painless in the early stages, which means it can be present for a considerable period before it is noticed or investigated. Because delay in diagnosis can affect the ease of surgical removal and the treatment required, any persistent, unexplained, or growing lump in a child deserves prompt medical evaluation.
These tumours are not caused by anything the parents did or did not do. Most arise because of genetic changes inside a single cell during the child’s development — changes that in the great majority of cases are sporadic and not inherited. A small number of children with certain inherited conditions are at higher lifetime risk for some sarcoma types, but this is uncommon and will be assessed during the diagnostic process.
Sarcoma subtypes your team may mention
Main types of soft-tissue sarcoma seen in children and adolescents
The term “non-rhabdo soft-tissue sarcoma” covers a large family of distinct tumour types. Each has its own biology and its own treatment implications. Here are the types most commonly seen in children and young people.
Common in teens & young adults
Synovial sarcoma
One of the more frequently encountered soft-tissue sarcomas in children and adolescents. Despite its name, it does not arise from joint tissue. It most often appears as a firm, slow-growing mass near a large joint — the knee, shoulder, or ankle — and can also occur in the head and neck or thorax. It is defined by a specific chromosomal translocation (X;18) that helps confirm the diagnosis. Synovial sarcoma tends to be sensitive to chemotherapy, and this is factored into the treatment plan.
- Can be present for months before diagnosis; not always painful early on
- MRI and molecular testing are key to accurate diagnosis
- Surgery with wide margins is the cornerstone of treatment
Infants & young children
Infantile fibrosarcoma
A soft-tissue sarcoma that occurs almost exclusively in children under four years of age, most often in infants under one year. It tends to arise in the distal limbs (hands and feet) or trunk. Despite its alarming appearance, infantile fibrosarcoma generally behaves far less aggressively than adult fibrosarcoma. Many cases carry a specific chromosomal change (ETV6-NTRK3 fusion) that makes the tumour sensitive to a targeted treatment approach. Surgery is usually the primary treatment, and the overall outlook for this age group is generally favourable compared with adult sarcomas.
- Often presents as a large, rapidly growing lump at birth or in early infancy
- Molecular testing for ETV6-NTRK3 fusion is standard before treatment decisions
- Chemotherapy may be used before surgery to shrink large or unresectable tumours
Older children & adolescents
Epithelioid sarcoma
A rare soft-tissue sarcoma that most commonly occurs in the distal extremities — particularly the fingers, hand, and forearm — and less commonly in the proximal (upper arm or thigh) or axial (trunk, perineum) locations. It often presents as a small, firm nodule or group of nodules under the skin, which can initially be mistaken for a benign lesion. Epithelioid sarcoma has a tendency to spread along tendons and fascial planes, and lymph node spread is more common with this type than with many other sarcomas. It requires specialist pathological assessment, as it can be difficult to distinguish from other conditions under the microscope without specific immunohistochemical testing.
- Can be mistaken for a cyst, granuloma, or benign skin lesion
- Specialised immunohistochemistry (INI-1 loss) is a key diagnostic feature
- Complete surgical excision is critical; recurrence risk is significant
Rare; tendons & aponeuroses
Clear cell sarcoma
A rare soft-tissue sarcoma that most often arises in tendons and aponeuroses (the flat, sheet-like tendons that attach muscles to bone) of the distal limbs, particularly around the foot, ankle, and knee. It most commonly affects adolescents and young adults. Clear cell sarcoma has a characteristic appearance under the microscope — cells with clear cytoplasm — and carries a specific chromosomal translocation (EWSR1-ATF1 or EWSR1-CREB1) that helps confirm the diagnosis. Despite originating in soft tissue rather than skin, it has similarities at a molecular level to melanoma of the skin, which is why it is sometimes called “melanoma of soft parts.” Surgery with wide margins is the primary treatment.
- Often presents near or around a joint after a history of minor trauma, causing delay in diagnosis
- Molecular confirmation is essential before treatment
- Lymph node assessment recommended given the tendency for lymphatic spread
Vascular tissue sarcomas
Angiosarcoma & haemangiopericytoma
A small group of sarcomas that arise from the cells lining blood vessels (angiosarcoma) or from the pericytes surrounding small vessels. These are uncommon in children. Paediatric haemangiopericytoma is now more precisely classified as infantile haemangiopericytoma (in young children) and adult-type haemangiopericytoma / solitary fibrous tumour (in older children and adolescents), which have different biological behaviours. When these tumours occur in infancy, they may behave similarly to infantile fibrosarcoma — with a more favourable outlook than the adult counterpart. Specialist pathological review is important to clarify the subtype.
- Infantile type (under 1 year) is generally less aggressive than adult type
- Location varies: can arise anywhere in the body
- Treatment decisions require expert sarcoma pathology review
This list covers the most common types. Many other rare soft-tissue sarcoma subtypes exist; the treatment of each is guided by its specific pathology and molecular features. — Return to the paediatric cancer hub
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child’s tumour deserves a team, not a single opinion.
Sarcoma subtypes are complex and the treatment depends on the exact pathology. At CION, every child’s case goes to a tumour board before any recommendation is made. We walk this journey with you.
The diagnostic and treatment journey
How a soft-tissue sarcoma in a child is diagnosed and treated — step by step
For a parent trying to make sense of what comes next, here is an honest, step-by-step description of what the diagnostic and treatment process typically involves when a soft-tissue sarcoma is suspected in a child.
First evaluation — physical examination and baseline investigations
When a lump or swelling prompts a visit to the doctor, the first step is a careful clinical assessment. The doctor will assess the lump: its size, consistency, depth, whether it moves freely or is fixed to surrounding tissue, and whether it is painful or tender. Blood tests are done to assess general health. At this stage, the clinical history matters — how long has the lump been present, has it grown, was there any preceding injury, are there any other symptoms such as unexplained weight loss, fatigue, or fever? These questions help determine the urgency and direction of further investigation.
Imaging — MRI of the primary site and CT of the chest
MRI (magnetic resonance imaging) is the preferred first imaging step for a suspicious soft-tissue mass. It does not use radiation, and it provides exceptional detail about the tumour’s relationship to the surrounding muscle, nerves, blood vessels, and bone — all of which are critical for surgical planning. A CT scan of the chest is done at the same time, because the lungs are the most common site for soft-tissue sarcoma to spread to. Depending on the tumour type and location, a PET-CT scan may also be requested to look for spread to lymph nodes or distant sites.
Biopsy — the critical step that determines everything that follows
A biopsy — taking a small sample of tissue from the tumour — is essential to confirm the diagnosis. This step should be planned carefully and performed by or in close discussion with the surgical team that will eventually remove the tumour, because the placement of the biopsy tract matters. A poorly placed biopsy can contaminate tissue planes and make limb-sparing surgery more difficult or impossible. In most cases a core-needle biopsy (a narrow needle that takes a tissue core) is used; in some situations a small incisional biopsy (a small surgical cut) is needed. The tissue is then sent to pathology for detailed analysis.
Pathology and molecular testing — confirming the exact subtype
The biopsy specimen is examined by an experienced pathologist under the microscope. Many soft-tissue sarcoma subtypes have a characteristic appearance, but specialist sarcoma pathology review is important because these tumours can be difficult to classify. Crucially, molecular and genetic testing is now a standard and essential part of sarcoma diagnosis. Many non-rhabdomyosarcoma sarcomas carry specific chromosomal translocations — rearrangements of chromosome segments — that help confirm the exact subtype and in some cases directly guide treatment decisions. For example, synovial sarcoma carries a translocation of chromosomes X and 18, and infantile fibrosarcoma carries an ETV6-NTRK3 fusion. These tests require enough tissue, which is another reason the biopsy needs to be carefully planned.
Tumour board review — the team makes the plan
Once all the investigations are complete, the case is reviewed at a multidisciplinary tumour board meeting. This brings together surgical oncologists experienced in sarcoma surgery, a medical oncologist, a radiation oncologist, a paediatric radiologist, and the pathologist who reviewed the specimen. The team jointly considers the tumour subtype, its size and location, the imaging findings, and the molecular test results. The outcome of this meeting is a written, personalised treatment plan. At CION, every case goes through this process before a treatment recommendation is made. We do not make decisions for individual patients in isolation.
Surgery — removing the tumour with a wide margin
For most localised soft-tissue sarcomas in children, surgery is the cornerstone of treatment. The surgical goal is to remove the tumour with a surrounding rim of normal tissue — called a wide margin — to ensure that no microscopic tumour cells are left behind at the edges. In limb tumours, limb-sparing surgery is almost always the goal: the aim is to remove the tumour completely while preserving a functioning limb. Achieving this requires careful pre-operative planning using the MRI images, and it is why sarcoma surgery should be performed by a surgeon experienced specifically in this field. For some tumours that cannot be safely removed at the outset, chemotherapy or radiation may be used first to reduce the size of the tumour before surgery is attempted.
Additional treatments — chemotherapy and radiation where indicated
Not every child with a soft-tissue sarcoma requires chemotherapy or radiation. Whether these are used depends on the tumour subtype, its size, whether the surgical margins were clear, and whether there is any evidence of spread. Radiation therapy is often used after surgery for larger tumours or those in locations where wide surgical margins are difficult to achieve. Chemotherapy has an established role in certain subtypes — particularly synovial sarcoma and infantile fibrosarcoma — and may be used before surgery (to shrink the tumour), after surgery (to reduce the risk of recurrence), or both. The specific chemotherapy agents, doses, and duration are determined by the medical oncologist based on established paediatric sarcoma treatment protocols.
You are not navigating this alone
Every family we walk with starts with one conversation
You deserve clear answers, a treatment plan that is explained fully, and a team that reviews your child’s case together — not in isolation. That is what we offer in every consultation.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your questions about soft-tissue sarcomas in children — answered
What is a soft-tissue sarcoma in a child?
A soft-tissue sarcoma is a type of cancer that grows in the soft connecting tissues of the body — including muscle, fat, blood and lymph vessels, nerves, tendons, and the tissue lining around joints. The word “sarcoma” means a cancer that begins in connective tissue (as distinct from carcinomas, which begin in the lining cells of organs). In children, soft-tissue sarcomas are relatively uncommon but important to recognise. The most common soft-tissue sarcoma in children is rhabdomyosarcoma, which arises in muscle. The group of soft-tissue sarcomas that do not involve the rhabdomyosarcoma family is often called “non-rhabdomyosarcoma soft-tissue sarcomas” (NRSTS). These include synovial sarcoma, fibrosarcoma, epithelioid sarcoma, clear cell sarcoma, and several others. Each type has its own pattern of behaviour, typical age of onset, and treatment approach. Soft-tissue sarcomas in children can appear anywhere in the body but most commonly arise in the limbs, the trunk, or the head and neck.
What is synovial sarcoma and does it come from joints?
Synovial sarcoma is one of the more common non-rhabdomyosarcoma soft-tissue sarcomas in children and young adults. Despite the name, synovial sarcoma does not actually arise from the synovial membrane (the lining of joints). The name comes from its microscopic appearance, which resembles synovial tissue, but molecular studies have confirmed that this tumour originates from primitive mesenchymal cells that can appear anywhere in the body. It most often occurs near — but not inside — large joints such as the knee, shoulder, ankle, or elbow. It can also arise in the head and neck, abdomen, and thorax. Synovial sarcoma is characterised by a specific chromosomal change — a translocation between chromosomes X and 18 — which is found in the great majority of cases and is a key part of confirming the diagnosis. Children and adolescents are among the most frequently affected age groups. The tumour often appears as a slow-growing, painful or painless lump near a joint and can be present for months or even years before a diagnosis is made.
What are the warning signs of a soft-tissue sarcoma in a child?
Soft-tissue sarcomas often present as a lump or swelling that may or may not be painful. Key features that make a lump worth evaluating promptly include: a lump that is larger than 5 centimetres (roughly the size of a golf ball) or that is growing; a lump that is deep within the body, beneath the muscle or fascia, rather than just under the skin; a lump that is firm, hard, or does not move freely; a lump that causes persistent pain, particularly at night; or a lump that returns after it seemed to resolve. Soft-tissue sarcomas do not always cause pain in the early stages, which is why they are sometimes discovered late. If a child has a persistent, unexplained lump — especially on a limb or in the trunk — that has been present for more than two to three weeks without an obvious explanation such as injury or infection, it deserves a medical evaluation. Not every lump is cancer; most are not. But sarcoma is the reason to evaluate lumps in children carefully and not simply wait to see if they resolve.
How is a soft-tissue sarcoma in a child diagnosed?
Diagnosis requires imaging and a biopsy. When a suspicious lump is found, MRI is the preferred imaging method for soft tissues — it provides detailed images of the tumour’s size, location, relationship to surrounding structures, and whether it extends into bone. A CT scan of the chest is usually done at the same time, because the lungs are a common site for soft-tissue sarcoma to spread. A PET-CT scan may also be used to look for distant spread. A biopsy — taking a sample of the tumour tissue — is essential to confirm the diagnosis. The type of biopsy (needle biopsy or surgical biopsy) is carefully planned, because the approach matters: a poorly planned biopsy can make later surgery more difficult. The tissue sample is then examined under the microscope by an experienced pathologist, and specialised molecular and genetic tests are performed, because many soft-tissue sarcomas have specific chromosomal changes that help confirm the subtype and guide treatment decisions.
What treatment options exist for soft-tissue sarcomas in children?
Treatment for soft-tissue sarcoma in children depends on the tumour type, its location, its size, and whether it has spread. For localised tumours that can be completely removed, surgery is the cornerstone of treatment. The aim is to remove the tumour with a rim of healthy tissue around it — what surgeons call a wide margin — while preserving the limb wherever possible. Radiation therapy may be used to treat any microscopic disease remaining after surgery, particularly for larger tumours or those in locations where achieving wide margins is difficult. Chemotherapy has an established role for some subtypes, particularly synovial sarcoma and certain others, though its benefit varies between the different non-rhabdomyosarcoma sarcoma types. For advanced or metastatic disease, a combination of chemotherapy, surgery to remove accessible disease, and radiation is typically involved. Treatment is planned and delivered by a multidisciplinary team that includes a surgical oncologist experienced in sarcoma surgery, a medical oncologist, a radiation oncologist, and pathologists with sarcoma expertise.
Will my child lose their limb if a sarcoma is in an arm or leg?
In most cases, limb-sparing surgery — also called limb-salvage surgery — is the goal when a soft-tissue sarcoma is in a limb. Advances in surgical technique, imaging, and the use of chemotherapy or radiation to shrink tumours before surgery mean that the majority of children with a limb sarcoma can be treated without amputation. However, achieving this depends on the tumour’s size, location, and its relationship to important blood vessels, nerves, and bone. For some cases where limb-sparing surgery cannot be performed safely while adequately removing the tumour, amputation may still be the safest choice — and in these situations it may give the best long-term outcome. This is a deeply personal conversation that the surgical team will have with your family after a full review of the imaging and pathology. At CION, every case is reviewed at a multidisciplinary tumour board so that the recommendation for surgery comes from a team consensus, not a single doctor’s opinion.
Have a question not answered here? Request a callback and a member of our paediatric oncology team will contact you.
Pediatric Cancer A–Z
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.